G. Liccardi
, L. Calzetta
, M. Milanese
, M. B. Bilò
, M. V. Liccardi
, I. Baiardini
, D. Gargano
, M. Lo Schiavo
, F. Madonna
, M. C. Montera
, A. Papa
, A. Pedicini
, F. Habetswallner
, A. Giordano
, P. Rogliani
1Department of Experimental Medicine, Postgraduate School of Respiratory Medicine, University of Rome Tor Vergata, Rome, Italy
2Department of Experimental Medicine, Unit of Respiratory Medicine, University of Rome Tor Vergata, Rome, Italy
3Division of Pulmonology, S. Corona Hospital, Pietra Ligure, Savona, Italy
4Department of Internal Medicine, Allergy Unit, University Hospital Ospedali Riuniti - Department of Clinical and Molecular Sciences, Marche Polytechnic University, Ancona, Italy
5Psychologist
6Department of Biomedical Science, Humanitas University, Milan, Italy
7High Speciality San Giuseppe Moscati Hospital, Allergy Unit, Avellino, Italy
8Department of Allergy and Clinical Immunology, G. Fucito Hospital and University Hospital, Salerno, Italy
9ASL (Sanitary District n. 12), Allergy Unit, Caserta, Italy
10ASL (Sanitary District), Avellino, Italy
11Division of Internal Medicine, Unit of Allergology, Fatebenefratelli Hospital, Benevento, Italy
12Division of Neurophysiology, A. Cardarelli Hospital, Naples, Italy
13Postgraduate School of Internal Medicine, University of Salerno, Salerno, Italy
HistoryPublished online: 15 March 2021
Accepted: 27 January 2021
Received: 12 December 2020
Adverse drug reaction; anxiety; bronchial asthma; bronchial obstruction; cholinergic tone; depression; increased cholinergic tone; hypersensitivity; nocebo effect; placebo challenge.